A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer.
Saved in:
| Title: | A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer. |
|---|---|
| Authors: | Graff JN; Division of Hematology/Medical Oncology, School of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA.; Division of Hematology and Oncology, VA Portland Health Care System, Portland, OR, USA., Smith CEP; Division of Hematology and Oncology, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA., Sokolova AO; Division of Hematology/Medical Oncology, School of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA., Qian DZ; Division of Hematology/Medical Oncology, School of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA., Beer TM; Division of Hematology/Medical Oncology, School of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA.; Division of Hematology and Oncology, VA Portland Health Care System, Portland, OR, USA., Latour E; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Bailey S; Division of Hematology/Medical Oncology, School of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA., Kreitner D; Division of Hematology/Medical Oncology, School of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA., Grivas P; Department of Medicine (Division Hematology/Oncology), University of Washington School of Medicine, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Schweizer MT; Department of Medicine (Division Hematology/Oncology), University of Washington School of Medicine, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Higano CS; Department of Medicine (Division Hematology/Oncology), University of Washington School of Medicine, Seattle, WA, USA., Alumkal JJ; Genitourinary Medical Oncology Section, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Vuky J; Division of Hematology/Medical Oncology, School of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA., Yu EY; Department of Medicine (Division Hematology/Oncology), University of Washington School of Medicine, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Cheng HH; Department of Medicine (Division Hematology/Oncology), University of Washington School of Medicine, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. |
| Source: | The oncologist [Oncologist] 2026 May 08; Vol. 31 (6). |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyag180 |
